PGFC
ACER

Peapack-Gladstone Financial Corp’s Acer Therapeutics Inc ACER Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-120
Closed -$4.45K – 332
2015
Q2 		$4.45K Hold
120
– – ﹤0.01% 320
2015
Q1 		$5.5K Hold
120
– – ﹤0.01% 328
2014
Q4 		$7.2K Hold
120
– – ﹤0.01% 305
2014
Q3 		$9.93K Hold
120
– – ﹤0.01% 294
2014
Q2 		$16.6K Hold
120
– – ﹤0.01% 291
2014
Q1 		$18.7K Hold
120
– – ﹤0.01% 289
2013
Q4 		$18.2K Hold
120
– – ﹤0.01% 281
2013
Q3 		$21.9K Hold
120
– – ﹤0.01% 279
2013
Q2 		$15.3K Buy
+120
New +$17.5K ﹤0.01% 285

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Peapack-Gladstone Financial Corp's ACER Position: Q3 2015 in Review

Peapack-Gladstone Financial Corp sold out of Acer Therapeutics Inc (ACER) in Q3 2015, closing a stake of 120 shares — an estimated $4.45K sold.

Peapack-Gladstone Financial Corp first reported a position in ACER in Q2 2013 and held it in 9 quarters. The position peaked at $21.9K in Q3 2013. 12 funds tracked by Wall St. Rank hold ACER as of Q3 2015.

  • Peapack-Gladstone Financial Corp reported no remaining Acer Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 120 Acer Therapeutics Inc shares in Q3 2015, an estimated $4.45K.
  • Peapack-Gladstone Financial Corp first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 9 quarters.
  • Peapack-Gladstone Financial Corp's Acer Therapeutics Inc position peaked at $21.9K in Q3 2013.
  • 12 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2015.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q3 2015, filed 12 Nov 2015.